Autologous bone marrow mesenchymal stem cell therapy in the subacute stage of traumatic brain injury by lumbar puncture

Experimental and Clinical Transplantation

Volumn 11, Issue 2, 2013, Pages 176-181

  Tian, Chunlei ^a,b   Wang, Xiongwei ^a,b   Wang, Xiaodan ^a   Wang, Lei ^a,b   Wang, Xuguang ^a,b   Wu, Shengmei ^a,b   Wan, Zhixian ^a,b  

^a CHINA THREE GORGES UNIVERSITY   (China)

^b Department of Neurosurgery   (China)

Author keywords

Cerebral lesion; Motor; Regenerative therapy; Transplant; Vegetative state

Indexed keywords

ADULT; ADVERSE OUTCOME; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTONOMIC NEUROPATHY; BRAIN FUNCTION; CELL COUNT; CELL ISOLATION; CONSCIOUSNESS; CONTROLLED STUDY; FEVER; HEADACHE; HUMAN; HUMAN CELL; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; OUTCOME ASSESSMENT; SUBARACHNOID SPACE; THERAPY EFFECT; TRAUMATIC BRAIN INJURY;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; BRAIN INJURIES; CONSCIOUSNESS; CONSCIOUSNESS DISORDERS; FEMALE; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; MOTOR SKILLS DISORDERS; PERSISTENT VEGETATIVE STATE; RECOVERY OF FUNCTION; REGENERATIVE MEDICINE; SPINAL PUNCTURE; SUBACUTE CARE; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876076089     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.2012.0053     Document Type: Article

References (34)

1. Zink BJ. Traumatic brain injury outcome: concepts for emergency care. Ann Emerg Med. 2001;37(3):318-332.
2. Curry P, Viernes D, Sharma D. Perioperative management of traumatic brain injury. Int J Crit Illn Inj Sci. 2011;1(1):27-35.
3. Arango MF, Videtta W, Puppo C. Chapter 15. Acute traumatic brain injury. In: Candelise L, Hughes R, Liberati A, Uitdehaag BM, Warlow C, eds. Evidence-based Neurology: Management of Neurological Disorders. 1st ed. Oxford, OX: Blackwell Publishing; 2007:142-150.
4. Wilkinson L, Lennox G. Head injury. In: Wilkinson L, Lennox G, eds. Essential Neurology. 4th ed. Oxford, OX: Blackwell Publishing; 2005:55-66.
5. Wislet-Gendebien S, Laudet E, Neirinckx V, Rogister B. Adult bone marrow: which stem cells for cellular therapy protocols in neurodegenerative disorders? J Biomed Biotechnol. 2012;2012:601560.
6. Sekiya I, Larson BL, Smith JR, Pochampally R, Cui JG, Prockop DJ. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells. 2002;20(6):530-541.
7. Kim HJ, Kim UJ, Vunjak-Novakovic G, Min BH, Kaplan DL. Influence of macroporous protein scaffolds on bone tissue engineering from bone marrow stem cells. Biomaterials. 2005;26(21):4442-4452.
8. Meinel L, Karageorgiou V, Fajardo R, et al. Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng. 2004;32(1):112-122.
9. Meinel L, Hofmann S, Betz O, et al. Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2. Biomaterials. 2006;27(28):4993-5002.
10. Pavlichenko N, Sokolova I, Vijde S, et al. Mesenchymal stem cells transplantation could be beneficial for treatment of experimental ischemic stroke in rats. Brain Res. 2008;1233:203-213.
11. Keimpema E, Fokkens MR, Nagy Z, et al. Early transient presence of implanted bone marrow stem cells reduces lesion size after cerebral ischaemia in adult rats. Neuropathol Appl Neurobiol. 2009;35(1):89-102.
12. Yoo SW, Kim SS, Lee SY, et al. Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model. Exp Mol Med. 2008;40(4):387-397.
13. Andrews EM, Tsai SY, Johnson SC, et al. Human adult bone marrow-derived somatic cell therapy results in functional recovery and axonal plasticity following stroke in the rat. Exp Neurol. 2008;211(2):588-592.
14. Jang DK, Park SI, Han YM, et al. Motor-evoked potential confirmation of functional improvement by transplanted bone marrow mesenchymal stem cell in the ischemic rat brain. J Biomed Biotechnol. 2011;2011:238409.
15. Kumar AA, Kumar SR, Narayanan R, Arul K, Baskaran M. Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: A phase I/II clinical safety and primary efficacy data. Exp Clin Transplant. 2009;7(4):241-248.
16. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood. 2004;103(5):1662-1668.
17. Hilfiker A, Kasper C, Hass R, Haverich A. Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: is there a future for transplantation? Langenbecks Arch Surg. 2011;396(4):489-497.
18. Lerner AJ. Disorders of consciousness and brain death. In: Lerner AJ, ed. Diagnostic Criteria in Neurology. 1st ed. Totowa, New Jersey: Humana Press Inc; 2006:69-78.
19. Brown AW, Elovic EP, Kothari S, Flanagan SR, Kwasnica C. Congenital and acquired brain injury. 1. Epidemiology, pathophysiology, prognostication, innovative treatments, and prevention. Arch Phys Med Rehabil. 2008;89(3 suppl 1):S3-S8.
20. Frey LC. Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia. 2003;44(suppl 10):11-17.
21. Nicholl J, LaFrance WC Jr. Neuropsychiatric sequelae of traumatic brain injury. Semin Neurol. 2009;29(3):247-255.
22. Potts MB, Adwanikar H, Noble-Haeusslein LJ. Models of traumatic cerebellar injury. Cerebellum. 2009;8(3):211-221.
23. Weiner LP. Definitions and criteria for stem cells. Methods Mol Biol. 2008;438:3-8.
24. Syková E, Jendelová P. Migration, fate and in vivo imaging of adult stem cells in the CNS. Cell Death Differ. 2007;14(7):1336-1342.
25. Mahmood A, Lu D, Qu C, Goussev A, Chopp M. Human marrow stromal cell treatment provides long-lasting benefit after traumatic brain injury in rats. Neurosurgery. 2005;57(5):1026-1031; discussion 1026-1031.
26. Mahmood A, Lu D, Qu C, Goussev A, Chopp M. Long-term recovery after bone marrow stromal cell treatment of traumatic brain injury in rats. J Neurosurg. 2006;104(2):272-277.
27. Cox CS Jr, Baumgartner JE, Harting MT, et al. Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children. Neurosurgery. 2011;68(3):588-600.
28. Walker PA, Shah SK, Harting MT, Cox CS Jr. Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation. Dis Model Mech. 2009;2(1-2):23-38.
29. Allers C, Sierralta WD, Neubauer S, Rivera F, Minguell JJ, Conget PA. Dynamic of distribution of human bone marrow-derived mesenchymal stem cells after transplantation into adult unconditioned mice. Transplantation. 2004;78(4):503-508.
30. Tolar J, O'shaughnessy MJ, Panoskaltsis-Mortari A, et al. Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells. Blood. 2006;107(10):4182-4188.
31. Walczak P, Zhang J, Gilad AA, et al. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke. 2008;39(5):1569-1574.
32. Mahmood A, Lu D, Chopp M. Marrow stromal cell transplantation after traumatic brain injury promotes cellular proliferation within the brain. Neurosurgery. 2004;55(5):1185-1193.
33. Paul C, Samdani AF, Betz RR, Fischer I, Neuhuber B. Grafting of human bone marrow stromal cells into spinal cord injury: a comparison of delivery methods. Spine (Phila Pa 1976). 2009;34(4):328-334.
34. Vercelli A, Mereuta OM, Garbossa D, et al. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis. 2008;31(3):395-405.